WPI: Income Statement for WATSON PHARMACEUTCLS

PERIOD ENDING		30-Jun-08	31-Mar-08	31-Dec-07	30-Sep-07
Total Revenue		622,636	626,949	627,335	594,706
Cost of Revenue		359,898	380,102	373,178	346,420

Gross Profit		262,738	246,847	254,157	248,286

	Operating Expenses
	Research Development	39,216	38,015	35,825	35,657
	Selling General and Administrative	104,295	106,633	108,284	112,491
	Non Recurring	-	-	-	(6,118)
	Others	20,190	20,179	44,158	44,159

	Total Operating Expenses	-	-	-	186,189


Operating Income or Loss		99,037	82,020	65,890	62,097

	Income from Continuing Operations
	Total Other Income/Expenses Net	7,748	2,584	(4,586)	7,136
	Earnings Before Interest And Taxes	102,802	88,587	68,815	65,510
	Interest Expense	6,931	6,796	8,997	10,125
	Income Before Tax	95,871	81,791	59,818	55,385
	Income Tax Expense	35,568	31,162	21,415	20,779
	Minority Interest	-	-	-	-

	Net Income From Continuing Ops	60,303	50,629	38,403	34,606

	Non-recurring Events
	Discontinued Operations	-	-	-	-
	Extraordinary Items	-	-	-	-
	Effect Of Accounting Changes	-	-	-	-
	Other Items	-	-	-	-


Net Income		60,303	50,629	38,403	34,606
Preferred Stock And Other Adjustments		-	-	-	-

Net Income Applicable To Common Shares		$60,303	$50,629	$38,403	$34,606

Add to Portfolio

Set Alert

Email to a Friend

•	Sector Analysis

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More